Luigi Meneghini, MD, Endocrinology, Dallas, TX, University of Texas Southwestern Medical Center

LuigiFMeneghiniMDMBA

Endocrinology Dallas, TX

Diabetes, Lipid Metabolism

Professor, Department of Internal Medicine, University of Texas Southwestern Medical Center, Executive Director, Global Diabetes Program, Parkland Health & Hospital System

Dr. Meneghini is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Meneghini's full profile

Already have an account?

Education & Training

  • Jackson Memorial Hospital - Jackson Health System
    Jackson Memorial Hospital - Jackson Health SystemFellowship, 2003
  • University of Miami
    University of MiamiMBA, Health Administration, 1999 - 2000
  • University of Miami School of Business
    University of Miami School of BusinessMBA, Health Care Management, 1999 - 2000
  • Jackson Memorial Hospital - Jackson Health System
    Jackson Memorial Hospital - Jackson Health SystemResidency, Internal Medicine, 1991
  • Jackson Memorial Hospital - Jackson Health System
    Jackson Memorial Hospital - Jackson Health SystemInternship, Internal Medicine, 1988 - 1989
  • Emory University School of Medicine
    Emory University School of MedicineClass of 1988
  • Emory University
    Emory UniversityBA, Chemistry and French, 1980 - 1984

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2014 - 2022
  • FL State Medical License
    FL State Medical License 1990 - 2021
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • Who’s Who in America Marquis, 2013
  • The Leading Physicians of the World International Association of Healthcare Professionals, 2013
  • Top Doctors:South Florida Castle Connolly, 2012
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Barriers to Initiating Insulin in Type 2 Diabetes Patients: Development of a New Patient Education Tool to Address Myths Misconceptions and Clinical Realities  
    Brod M, Alolga SL, Meneghini L, The Patient, 6/1/2014
  • SOLVE Study Group Safety of once-daily insulin detemir in patients with type 2 diabetes treated with oral hypoglycemic agents (OHAs) in routine clinical practice  
    Ross S, Dzida G, Ji Q, Kaiser M, Ligthelm R, Meneghini L, Nazeri A, Orozco-Beltran D, Pan C, Svendsen AL, J Diabetes, 5/1/2014
  • A patient-level analysis of efficacy and hypoglycaemia outcomes across treat-to-target trials with insulin glargine added to oral antidiabetes agents in people with ty...  
    DeVries H, Meneghini L, Barnett AH, Reid T, Dain MP, Landgraf W, Vlajnic A, Traylor L, Bergenstal RM, European Endocrinology, 1/1/2014
  • Join now to see all

Books/Book Chapters

Abstracts/Posters

  • Lower within-subject variability in mean blood glucose concentration with insulin degludec vs. in-sulin glargine: a meta-analysis of patients with T2D
    Meneghini L, Harris S, Evans M, Rasmussen S, Johansen T, Pieber T, World Diabetes Congress, 12/1/2013
  • Reduced risk of hypoglycaemia with insulin degludec vs. insulin glargine in patients with type 2 diabetes and a BMI >30 kg/m2: a meta-analysis of five randomised tr...
    Philis-Tsimikas A, Rodbard HW, Meneghini LF, Kapur K, Endahl L, Russell-Jones DL, World Diabetes Congress, 12/1/2013
  • Reduced Risk of Hypoglycemia with Insulin Degludec vs. Insulin Glargine in Patients with Type 2 Diabetes and a BMI >30 kg/m(2): A Meta-analysis of 5 Randomized Trials
    Rodbard HW1, Meneghini LF, Russell-Jones DL, Kapur R, Endahl L, Kapor J, Philis-Tsimikas A, Can J Diabetes, 10/1/2013
  • Join now to see all

Lectures

  • Inpatient management of diabetes 
    12/1/2013
  • Ultra-Long Acting Basal Insulin Analogs: Challenges & Opportunities 
    11/1/2013
  • Advances in GLP1 Therapy: Current Agents and Combinations 
    11/1/2013
  • Join now to see all

Other

  • Update on the use of detemir insulin in the management of type 2 diabetes 
    Meneghini LF, Sheik A, US Endocrinology
    1/1/2008
  • Managing Type 2 Diabetes in Ethnic Minority Populations 
    Kahn K, Meneghini L, Clinical Medicine Today: Diabetes Newsletter
    1/1/2008
  • Current Treatment Options for a Type 2 Diabetes Patient Not Controlled on OADs 
    Meneghini LF, Pri-Med Online
    http://www.pri-med.com
    1/1/2008
  • Join now to see all

Press Mentions

  • Funeral Service for Capt. Robert Michael Hamaty, OD
    Funeral Service for Capt. Robert Michael Hamaty, ODJuly 11, 2020 09:41
  • New Customers and Partnerships Contribute To
    New Customers and Partnerships Contribute ToJanuary 25, 2019 21:59
  • Early Insulin: Better First Treatment for Type 2?
    Early Insulin: Better First Treatment for Type 2?January 13, 2016 18:50

Professional Memberships

Other Languages

  • Spanish, French, Italian

Hospital Affiliations